Conclusions
OAC therapy was associated with reduced incidence of dementia in patients with AF. However, on account of the high heterogeneity, low SOE, and no statistical result in observational window subgroup analysis, the results were limited. Further well-designed studies are needed to build the reliable link between OAC use and the reduced risk of developing dementia.